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Background
Spontaneous tropism changes (from R5 to non-R5 or
vice-versa) were observed in approximately 10% of
patients between screening and study baseline in the
maraviroc (MVC) clinical trials. Little is known of the
biology of these apparent short-term tropism
fluctuations.
Methods
Population-based and “deep” V3-loop sequencing were
performed in 53 MVC recipients in the MERIT, MOTI-
VATE and A4001029 studies who spontaneously chan-
ged tropism readout by the original Trofile assay
between screening and baseline (~4-8 weeks) and 72
randomly sampled patients who did not change. Trop-
ism was inferred by “geno2pheno” with previously
defined cutoffs: 2% X4 prevalence with a 3.5% false-posi-
tive rate (fpr) for “deep” sequencing; 5.75% fpr for popu-
lation-based sequencing.
Results
Patients changing Trofile readout from R5 to non-R5 had
significantly higher screening non-R5 prevalence by
“deep” sequencing than those who remained R5, and this
increased slightly by the baseline timepoint (Table 1).
Similarly, patients who changed tropism from non-R5 to
R5 in the A4001029 trial had a lower percentage of non-
R5 viruses at screening and baseline. Although there was
no difference in total viral load, absolute CXCR4-using
plasma virus load was higher in those who changed trop-
ism at screening (2.7 vs. 0 log10 copies/mL, p=0.02 in
M E R I T ;3 . 1v s .0l o g 10 copies/mL, p<0.0001 in MOTI-
VATE) and baseline (3.0 vs. 0 log10 copies/mL, p=0.04 in
M E R I T ;3 . 8v s .0l o g 10 copies/mL, p<0.0001 in MOTI-
V A T E ) .N o n - R 5w a sr e p o r t e da ts c r e e n i n gi n2 6 %a n d
49% of patients who changed phenotype to non-R5 by
population and deep-sequencing, respectively.
Conclusions
In most cases, the prevalence of non-CCR5 usage
inferred from “deep” sequencing was stable over the
short term between screening and baseline. Where
apparent phenotypic tropism changes from R5 to non-
R5 occurred, non-R5 virus was generally detectable at
the screening timepoint by genotype, coupled with rela-
tively small increases in non-R5 virus by baseline. Small
variations in CXCR4-using HIV populations around the
phenotypic assay detection limit, rather than coreceptor
switch, contributed to apparent tropism switching from
R5 to non-R5.
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Table 1
# Genotyped Screening X4% [IQR] Baseline X4% [IQR]
No Change Changed No Change Changed p No Change Changed p
MERIT 25 13 0 [0-0] 1.9 [0-3.3] 0.01 0 [0-0.1] 7 [0-16.3] 0.04
MOTIVATE 25 32 0 [0-0.1] 2.4 [0.1-21.3] 0.0001 0 [0-0.1] 9.1 [0.4-32.7] <0.0001
A4001029 22 8 5.0 [0.2-91.5] 1.8 [0.4-30.6] 0.5 4.3 [0-76.6] 0.4 [0-47.5] 0.3
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